Drugs / Stulln Eyedrops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05107791 | Mar → Aug 2021 | asthenopia, eye accommodation disease | Pacific University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stulln Eyedrops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05107791 ↗ |
| Route | Topical | “Stulln eyedrops will be applied to the anterior surface of cornea” NCT05107791 ↗ |